Dr Marc Tischkowitz - University of Cambridge, UK
Dr Tischkowitz is a University Reader and Honorary Consultant in the Department of Medical Genetics at Cambridge. He completed his medical degree in 1993 and trained in Medical Oncology before completing his CCST in Medical Genetics. From 1999-2002 he undertook a PhD researching the role of Fanconi anemia gene mutations in the development of sporadic acute myeloid leukaemia. He held a Consultant post at Great Ormond Street Hospital before moving to McGill University, Montreal in 2005 where he worked on Faculty for six years before coming to Cambridge. Much of his research has been on the Fanconi Anemia genes and hereditary breast cancer predisposition but his interests cover all areas of hereditary cancer and translating the recent advances in genomic technology into clinical practice.
Dr Loydie Jerome-Majewska - Centre for Research in Reproduction and Development - McGill University, Co-Director
Dr. Jerome-Majewska is an associate professor in the Department of Pediatrics at McGill University and a scientist in the Child Health and Human Development Program at the McGill University Health Centre Research Institute.
Members of the Jerome-Majewska laboratory use the mouse to study the genetic and cellular basis of morphogenesis during the embryonic period. The goals of the research program are (1) to use forward genetics to identify genes responsible for malformations in human and mouse during pregnancy; and (2) to use reverse genetics in the mouse model to characterize the cellular pathways regulated by genes implicated in congenital malformations.
Dr Natalie Prescott - Department of Medical and Molecular Genetics, King’s College London.
Dr Prescott's interests are identifying the genetic causes of common disorders, particularly the inflammatory bowel diseases (IBD): Crohn’s disease (CD), ulcerative colitis (UC) and rarer forms such as orofacial granulomatosis (OFG). Exploring the microbiome and transcriptome of the human gastrointestinal tract to help understand the role of host genetic variation in the aetiology of disease.
Andrew G. L. Douglas - University of Southampton
Dr Andrew Douglas is a consultant clinical geneticist at the Wessex Clinical Genetics Service based in Southampton, UK, and also holds an honorary senior clinical lecturer position at the University of Southampton. His particular research interests include genetic neuromuscular and neurodegenerative diseases, RNA splicing, oligonucleotide therapeutics and the application of genome-based technologies to the diagnosis and treatment of genetic disorders.
Martine Dunnwald - University of Iowa
Her research uses a combination of cell culture from patients and unique murine lines and in vivo murine models to study craniofacial development and cutaneous tissue repair. The goal of the research program are (1) to identify gene regulatory networks; and (2) to understand the cellular processes contributing to craniofacial development and tissue repair.
Stefan Meyer - The University of Manchester
Dr Stefan Meyer is a paediatric oncologist at the Royal Manchester Children’s and the Christie Hospital. He studied medicine in Hamburg, Manchester and London and trained in Paediatrics and Paediatric Oncology in Manchester. He has a special interest clinically in cancer-associated genetic disorders, in particular Fanconi anaemia and other DNA damage response defects, and investigates malignant transformation associated with inherited predisposition.
Dr Pedro Rocha - National Institutes of Health (NIH)
Dr Rocha is a Stadtman Investigator at NIH. His current interests are DNA packaging mechanisms in mammals, characterization of signaling pathways known to regulate early mouse development to understand the contribution of nuclear organization to gene regulation during early cell fate decisions and finally understanding how DNA organization impacts cell behavior, and ultimately animal development and health as well as the mechanisms through which DNA folding itself is established and regulated, and which proteins are involved in these processes.
Dr Jenny Tullet - School of Biosciences, University of Kent, UK
Dr Tullet is a Senior Lecturer at the University of Kent. Her background covers ageing biology, transcriptional regulation and model organism genetics,. Ageing is a major risk factor for many diseases but research shows that it is possible to modulate the ageing process to improve health and increase lifespan. Members of the Tullet laboratory use the nematode worm C. elegans to study the underlying molecular mechanisms of the ageing process. This knowledge could eventually allow us to improve the ageing process and relieve some of the suffering associated with it.